Oxidative and Nitrosative Stress in Major Depressive Disorder: A Case Control Study
Aditya Somani1, Abhishek Kumar Singh2, Bandna Gupta1
1Department of Psychiatry, King George's Medical University, Lucknow 226003, India.
Brain Sciences
|February 25, 2022
Summary
Major depressive disorder (MDD) involves oxidative and nitrosative stress, which are linked in families. This study found higher oxidative stress markers and lower nitrites in MDD patients and their relatives, suggesting a familial link.
Area of Science:
- Neuroscience
- Biochemistry
- Psychiatry
Background:
- Oxidative stress and nitric oxide (NO) pathway alterations are implicated in major depressive disorder (MDD).
- These pathways interact but haven't been studied simultaneously in MDD.
- This study investigated oxidative and nitrosative stress in neutrophils (PMNs) of drug-naive MDD patients and their relatives.
Purpose of the Study:
- To assess and compare oxidative and nitrosative stress markers in PMNs of drug-naive MDD patients and their first-degree relatives.
- To explore the familial association of these stress pathways in MDD.
Main Methods:
- Included 29 drug-naive MDD patients, 27 healthy first-degree relatives, and controls (aged 18-45).
- Measured reactive oxygen species (ROS), nitrites, neuronal NO synthase (nNOS), myeloperoxidase in PMNs, and serum cortisol.
Main Results:
- MDD patients showed significantly higher ROS, myeloperoxidase, nNOS mRNA in PMNs, and serum cortisol compared to controls.
- First-degree relatives also exhibited increased myeloperoxidase and serum cortisol.
- Both patients and relatives had significantly lower PMN and plasma nitrite levels.
- Positive correlations were found between ROS, nitrite levels, and serum cortisol in MDD patients and their relatives.
Conclusions:
- Neutrophil oxidative/nitrosative stress, plasma nitrite, and serum cortisol are positively correlated between MDD patients and their first-degree relatives.
- Findings suggest a familial component to these biochemical alterations in MDD.
- Further research with larger samples is needed to validate these pathways as potential early biomarkers for psychopathology risk.
Related Concept Videos
Depressive Disorders: Etiology
178
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
178
Depressive Disorders: MDD and Dysthymia
232
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
232
Introduction to Stress and Lifestyle
259
Stress is a multifaceted response to events perceived as challenging or threatening, highlighting physical, emotional, cognitive, and behavioral reactions. Physically, stress can lead to fatigue, sleep disruptions, and various health issues such as frequent colds, chest pains, and nausea. Emotionally, it can manifest as anxiety, depression, irritability, and anger triggered by both minor and major life events. Cognitively, it may result in difficulty in concentration, memory, and...
259
Antidepressant Drugs: MAOIs and Other Agents
401
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
401


